시장보고서
상품코드
1756481

무세포 태아 DNA 검사 시장 : 키트별, 샘플 유형별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Cell Free Fetal DNA Testing Market, By Kits, By Sample Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 400 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

무세포 태아 DNA 검사 시장 규모는 2024년에 16억 5,412만 달러로 2024-2032년에 걸쳐 CAGR 6.5%로 성장할 전망입니다.

무세포 태아 DNA 검사 시장 - 시장 역학

비침습적 임신 전 검사 수요 증가

비침습적 임신 전 검사(NIPT)에 대한 선호도가 증가하고 있는 것이 세포 자유 태아 DNA 검사 시장의 주요 성장 요인입니다. 임신부 및 의료 제공자는 cffDNA 검사가 양수 검사 같은 침습적 절차보다 안전한 대안을 제공하며 유산 위험을 줄이기 때문에 선호합니다. 또한 유전적 질환의 조기 발견은 임신 관리 개선과 정보에 기반한 의사결정을 가능하게 합니다. 기술의 발전으로 검사 정확도가 향상되고 비용이 감소하여 cffDNA 검사가 더욱 쉽게 이용할 수 있게 되었습니다. 태아 건강 및 유전적 질환에 대한 인식이 높아짐에 따라 수요가 더욱 증가하여 전 세계적으로 시장 성장이 가속화되고 있습니다.

무세포 태아 DNA 검사 시장 - 주요 인사이트

당사의 리서치 애널리스트에 따르면, 전 세계 무세포 태아 DNA 검사 시장은 2024년부터 2032년까지 연평균 약 6.5%의 성장률을 보일 것으로 예상됩니다.

2024년의 키트별 부문에서는 PCR & qPCR 기반 cffDNA 검사 키트 부문이 시장을 독점하고 있습니다.

최종 사용자별로 2024년에 가장 수익을 올린 것은 진단 실험실 부문이었습니다.

지역별로는 2024년 북미가 가장 높은 수익을 올린 지역이었습니다.

무세포 태아 DNA 검사 시장 - 세분화 분석

전 세계 무세포 태아 DNA 검사 시장은 키트, 최종 사용자, 샘플 유형 및 지역 등 4가지 부문으로 나뉩니다.

키트에 따라 무세포 태아 DNA 검사 시장은 무세포 DNA 추출 및 정제 키트, PCR 및 qPCR 기반 cffDNA 검사 키트, NGS 기반 cffDNA 검사 키트로 세분화됩니다. 추출 및 정제 키트는 모체 혈액에서 고품질 태아 DNA를 분리하는 데 필수적이며, 정확한 검사의 기반을 형성합니다. PCR 및 qPCR 기반 키트는 특정 유전적 표지자 및 변이를 신속하고 비용 효율적으로 검출하기 위해 증폭 기술을 사용합니다. 반면 NGS 기반 cffDNA 검사 키트는 다중 염색체 이상을 높은 민감도와 정확도로 검출하는 포괄적인 유전적 분석을 제공하기 위해 고급 차세대 시퀀싱 기술을 활용합니다. 이 중 PCR 및 qPCR 기반 cffDNA 테스트 키트는 정확성, 경제성, 빠른 처리 시간의 균형으로 현재 시장을 지배하고 있으며, 전 세계적으로 임상 환경에서 널리 선호되고 있습니다.

최종 사용자에 따라 무세포 태아 DNA 테스트 시장은 병원, 산부인과, 진단 실험실, 학술 및 연구 기관으로 분류됩니다. 병원은 포괄적인 산전 진료를 제공하며, cffDNA 검사를 정기 검진에 통합해 다양한 환자층을 대상으로 합니다. 산부인과 클리닉은 산모와 태아 건강에 특화된 서비스를 제공하며 개인 맞춤형 검사 옵션을 제공합니다. 진단 실험실은 의료진에게 고효율, 전문적인 검사 서비스를 제공해 정확성과 신속한 결과 확보에 핵심 역할을 합니다. 학술 및 연구 기관은 검사 기술 개발과 임상 연구를 통해 시장 발전에 기여합니다. 이 중 진단 실험실은 전문적인 인프라, 전문성, 대규모 검사를 효율적으로 처리할 수 있는 능력으로 인해 시장을 주도하며, 전 세계 cffDNA 검사 서비스의 중심 허브로 자리매김했습니다.

무세포 태아 DNA 검사 시장 - 지역적 인사이트

지역적으로 세포 자유 태아 DNA 검사 시장은 북미, 아시아태평양, 라틴 아메리카, 유럽, 중동, 아프리카 지역에 걸쳐 분포되어 있습니다. 이 지역은 비즈니스 유치 국가에 따라 추가로 구분됩니다.

북미는 주로 미국과 캐나다에 의해 촉진된 무세포 태아 DNA 검사 시장에서 지배적인 지역입니다. 이 지역은 첨단 의료 인프라, 최신 기술의 높은 채택률, 산전 건강에 대한 높은 인식의 혜택을 받고 있습니다. 유리한 보험 환급 정책과 주요 시장 참여자의 존재는 시장 성장을 더욱 촉진합니다. 또한, 유전 연구에 대한 투자 증가와 비침습적 산전 검사에 대한 수요 증가가 북미의 선도적 위치를 강화하여, 이 지역을 전 세계에서 가장 큰 cffDNA 검사 시장 중 하나로 만들고 있습니다.

아시아태평양 지역은 중국, 인도, 일본 등 국가들을 중심으로 세포 자유 태아 DNA 검사 시장에서 급속한 성장을 보이고 있는 또 다른 주요 지역입니다. 의료비 지출의 증가, 산전 진단에 대한 인식의 제고, 의료 인프라의 확장이 시장 확장을 촉진하고 있습니다. 중산층 인구의 증가와 첨단 검사 기술에 대한 접근성 향상도 수요를 부추기고 있습니다. 또한, 모자 건강 개선 및 민간 부문 참여 확대를 목표로 한 정부 정책이 이 지역의 시장 성장을 가속화하고 있으며, 아시아태평양은 cffDNA 검사 분야의 주요 신흥 시장으로 자리매김하고 있습니다.

무세포 태아 DNA 검사 시장 - 경쟁 구도

무세포 태아 DNA 검사 시장의 경쟁 환경은 혁신적인 신생 기업과 함께 기존 생명 공학 및 분자 진단 기업에 의해 형성되어 있습니다. QIAGEN, Thermo Fisher Scientific, Takara Bio, Promega와 같은 선도적인 기업들은 정확성, 민감도 및 사용 편의성에 중점을 둔 첨단 검사 키트와 기술로 시장을 지배하고 있습니다. 이 기업들은 검사 성능을 향상시키고 규제 기준을 준수하기 위해 연구 개발에 상당한 투자를 하고 있습니다. 신흥 기업들은 진단 능력을 확대하기 위해 새로운 시퀀싱 및 생물정보학 솔루션을 도입하고 있습니다. 이러한 경쟁 환경은 지속적인 혁신을 촉진하여 전 세계적으로 비침습적 산전 검사의 시장 성장과 폭넓은 채택을 촉진하고 있습니다.

목차

제1장 무세포 태아 DNA 검사 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 무세포 태아 DNA 검사의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 무세포 태아 DNA 검사 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 틀 분석

제5장 무세포 태아 DNA 검사 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 무세포 태아 DNA 검사 시장 상황

  • 무세포 태아 DNA 검사 시장 점유율 분석(2023년)
  • 주요 제조업체별 분석 데이터
    • 베테랑 선수의 분석
    • 신흥기업의 분석

제7장 무세포 태아 DNA 검사 시장 - 키트별

  • 개요
    • 키트별 부문 점유율 분석
    • 무세포 DNA 추출 및 정제 키트
    • PCR 및 qPCR 기반 cffDNA 검사 키트
    • NGS 기반 cffDNA 검사 키트

제8장 무세포 태아 DNA 검사 시장 : 샘플 유형별

  • 개요
    • 샘플 유형별 부문 점유율 분석
    • 모체 혈장/혈청
    • 소변 cfDNA

제9장 무세포 태아 DNA 검사 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원
    • 산부인과
    • 진단 실험실
    • 학술기관 및 연구기관

제10장 무세포 태아 DNA 검사 시장 : 지역

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 영국
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 한국
    • 일본
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 무세포 태아 DNA 검사 산업

  • 경쟁 대시보드
  • 기업 프로파일
    • QIAGEN
    • Thermo Fisher Scientific
    • Takara Bio
    • Nonacus
    • Promega
    • VWR
    • OmegabIoTek
    • Nvigen
    • BioChain
    • Norgen BIoTek
    • 기타

제12장 애널리스트의 전방위 전망

HBR 25.07.02

REPORT HIGHLIGHT

Cell Free Fetal DNA Testing Market size was valued at USD 1,654.12 Million in 2024, expanding at a CAGR of 6.5% from 2024 to 2032.

The Cell Free Fetal DNA (cffDNA) Testing Market involves the development, production, and sale of non-invasive prenatal testing (NIPT) technologies that analyze fetal DNA fragments circulating in a pregnant woman's blood. This testing helps detect genetic abnormalities, such as Down syndrome, Edwards syndrome, and Patau syndrome, early in pregnancy without risk to the fetus. The market includes diagnostic laboratories, healthcare providers, and biotechnology companies offering cffDNA-based screening kits and services. Growing awareness of prenatal health, increasing demand for safe and accurate fetal genetic testing, and advancements in genomic technologies are driving the market's expansion globally.

Cell Free Fetal DNA Testing Market- Market Dynamics

Rising Demand for Non-Invasive Prenatal Testing

The increasing preference for non-invasive prenatal testing (NIPT) is a key driver of the Cell Free Fetal DNA Testing Market. Expectant mothers and healthcare providers favor cffDNA testing because it offers a safer alternative to invasive procedures like amniocentesis, reducing the risk of miscarriage. Additionally, early detection of genetic disorders enables better pregnancy management and informed decision-making. Advances in technology have improved test accuracy and reduced costs, making cffDNA testing more accessible. Growing awareness about prenatal health and genetic conditions further boosts demand, accelerating market growth worldwide.

Cell Free Fetal DNA Testing Market- Key Insights

According to our research analyst, the global Cell Free Fetal DNA Testing Market is expected to develop at a CAGR of approximately 6.5% between 2024-2032.

Segmented by Kits in 2024, the PCR & qPCR-Based cffDNA Testing Kits category dominated the market.

Based on End User, the Diagnostic Laboratories segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Cell Free Fetal DNA Testing Market- Segmentation Analysis:

The global Cell Free Fetal DNA Testing Market is divided into Four categories: Kits, End User, Sample Type, and Region.

By kits, the Cell Free Fetal DNA Testing Market is segmented into Cell-Free DNA Extraction & Purification Kits, PCR & qPCR-Based cffDNA Testing Kits, and NGS-Based cffDNA Testing Kits. Extraction and purification kits are essential for isolating high-quality fetal DNA from maternal blood, forming the foundation for accurate testing. PCR and qPCR-based kits use amplification techniques to detect specific genetic markers and mutations quickly and cost-effectively. Meanwhile, NGS-based cffDNA testing kits employ advanced next-generation sequencing technology to provide comprehensive genetic analysis, including the detection of multiple chromosomal abnormalities with higher sensitivity and precision. Among these, PCR & qPCR-based cffDNA Testing Kits currently dominate the market due to their balance of accuracy, affordability, and faster turnaround time, making them widely preferred in clinical settings globally.

By end user, the Cell Free Fetal DNA Testing Market is categorized into Hospitals, Maternity Clinics, Diagnostic Laboratories, and Academic & Research Institutions. Hospitals offer comprehensive prenatal care and often integrate cffDNA testing as part of routine screenings, catering to a broad patient base. Maternity clinics focus on specialized maternal and fetal health services, providing personalized testing options. Diagnostic laboratories play a critical role by offering high-throughput, specialized testing services to healthcare providers, ensuring accuracy and timely results. Academic and research institutions contribute by advancing testing technologies and conducting clinical studies. Among these, diagnostic laboratories dominate the market due to their specialized infrastructure, expertise, and ability to handle large volumes of tests efficiently, making them central hubs for cffDNA testing services worldwide.

Cell Free Fetal DNA Testing Market- Geographical Insights

Geographically, the Cell Free Fetal DNA Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Cell Free Fetal DNA Testing Market, driven primarily by the United States and Canada. The region benefits from advanced healthcare infrastructure, high adoption of cutting-edge technologies, and strong awareness about prenatal health. Favorable reimbursement policies and the presence of key market players further boost market growth. Additionally, increasing investments in genetic research and growing demand for non-invasive prenatal testing contribute to North America's leading position, making it one of the largest markets globally for cffDNA testing.

Asia Pacific is another key region showing a rapid growth in the Cell Free Fetal DNA Testing Market, led by countries like China, India, and Japan. Rising healthcare expenditure, increasing awareness of prenatal diagnostics, and expanding healthcare infrastructure are driving market expansion. The growing middle-class population and improving access to advanced testing technologies are fueling demand. Additionally, government initiatives aimed at improving maternal and child health and increasing private sector participation are accelerating market growth in this region, positioning Asia Pacific as a major emerging market for cffDNA testing.

Cell Free Fetal DNA Testing Market- Competitive Landscape:

The competitive landscape of the Cell Free Fetal DNA Testing Market is shaped by established biotechnology and molecular diagnostics companies alongside innovative startups. Leading players like QIAGEN, Thermo Fisher Scientific, Takara Bio, and Promega dominate with advanced testing kits and technologies focused on accuracy, sensitivity, and ease of use. These companies invest significantly in R&D to enhance test performance and comply with regulatory standards. Emerging firms are introducing novel sequencing and bioinformatics solutions to expand diagnostic capabilities. This competitive environment fosters continuous innovation, driving market growth and broader adoption of non-invasive prenatal testing worldwide.

Recent Developments:

In April 2024, QIAGEN launched a new, streamlined cffDNA extraction kit aimed at reducing sample processing time while maintaining high purity and yield.

In January 2025, Thermo Fisher Scientific expanded its prenatal genetic testing portfolio by acquiring a specialist NGS-based cffDNA testing startup to enhance its market reach and technological offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL FREE FETAL DNA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • QIAGEN
  • Thermo Fisher Scientific
  • Takara Bio
  • Nonacus
  • Promega
  • VWR
  • Omegabiotek
  • Nvigen
  • BioChain
  • Norgen Biotek
  • Others

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY KITS - MARKET ANALYSIS, 2019 - 2032

  • Cell-Free DNA Extraction & Purification Kits
  • Pcr & Qpcr-Based Cffdna Testing Kits
  • Ngs-Based Cffdna Testing Kits

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY SAMPLE TYPE - MARKET ANALYSIS, 2019 - 2032

  • Maternal Plasma/Serum
  • Urine cfDNA

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Maternity Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutions

GLOBAL CELL FREE FETAL DNA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Free Fetal DNA Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Free Fetal DNA Testing Market Snippet by Kits
    • 2.1.2. Cell Free Fetal DNA Testing Market Snippet by Sample Type
    • 2.1.3. Cell Free Fetal DNA Testing Market Snippet by End User
    • 2.1.4. Cell Free Fetal DNA Testing Market Snippet by Country
    • 2.1.5. Cell Free Fetal DNA Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Free Fetal DNA Testing Key Market Trends

  • 3.1. Cell Free Fetal DNA Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Free Fetal DNA Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Free Fetal DNA Testing Market Opportunities
  • 3.4. Cell Free Fetal DNA Testing Market Future Trends

4. Cell Free Fetal DNA Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Free Fetal DNA Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Free Fetal DNA Testing Market Landscape

  • 6.1. Cell Free Fetal DNA Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Free Fetal DNA Testing Market - By Kits

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Kits, 2023 & 2032 (%)
    • 7.1.2. Cell-Free DNA Extraction & Purification Kits
    • 7.1.3. PCR & qPCR-Based cffDNA Testing Kits
    • 7.1.4. NGS-Based cffDNA Testing Kits

8. Cell Free Fetal DNA Testing Market - By Sample Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
    • 8.1.2. Maternal Plasma/Serum
    • 8.1.3. Urine cfDNA

9. Cell Free Fetal DNA Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Maternity Clinics
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Academic & Research Institutions

10. Cell Free Fetal DNA Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Free Fetal DNA Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Free Fetal DNA Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Free Fetal DNA Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Free Fetal DNA Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Free Fetal DNA Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Kits, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell Free Fetal DNA Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. QIAGEN
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. Takara Bio
    • 11.2.4. Nonacus
    • 11.2.5. Promega
    • 11.2.6. VWR
    • 11.2.7. Omegabiotek
    • 11.2.8. Nvigen
    • 11.2.9. BioChain
    • 11.2.10. Norgen Biotek
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제